OncoSec Medical Inc (ONCSQ)

[Titan V]

I am looking forward to the TAP collaboration announcement(s) for TRACE, which according to PD at Biotech Showcase "will be announced shortly." I took this as sometime this quarter.

I wouldn't be surprised to see KU Leuven teaming up with a checkpoint inhibitor provider to use ONCS's TRACE device.

As I've posted before, KU Leuven is good at spinning out biotechs and collaborating with big pharma. Here's another such spin-out and collaboration:
http://sciencebusiness.net/news/67844/KU-Leuven-spin-out-in-Alzheimers-alliance-with-Roche-worth-a-potential-and-euro%3B500M

Roche's Tecentriq is a checkpoint inhibitor (PD-L1). Roche would be a great TRACE collaborator IMO.